Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
03/2003
03/11/2003US6531604 Useful as medicines having an osteogenesis promoting effect and chondrogensis promoting effect.
03/11/2003US6531582 2-O-(9z,12z-octadecadienoyl)-3-O-[α-D-galactopyranosyl-(1″-6′)-O-α-D-galactopyranosyl]glycerol and pharmaceutical composition containing the same
03/11/2003US6531580 Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same
03/11/2003US6531511 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
03/11/2003US6531492 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/11/2003US6531485 Prostaglandin agonists
03/11/2003US6531479 Anti-cancer compounds
03/11/2003US6531474 Inhibitors of caspases
03/11/2003US6531459 Vitamin D derivatives with phosphorus atoms in the side chains
03/11/2003US6531449 Hexahydropyrazolo[4,3,-c]pyridine metabolites
03/11/2003CA2264254C Phosphinic acid amides as matrix metalloprotease inhibitors
03/10/2003CA2401358A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
03/10/2003CA2401319A1 Use of statins to inhibit formation of osteoclasts
03/06/2003WO2003019146A2 High throughput screening assays using fatty acid synthetic enzymes
03/06/2003WO2003018799A2 Modulators of bone homeostasis identified in a high-throughput screen
03/06/2003WO2003018756A2 Methods for preparing purified prostaglandin e synthase
03/06/2003WO2003018640A2 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids
03/06/2003WO2003018619A2 Antimicrobial and anti-inflammatory peptides
03/06/2003WO2003018579A1 Alkyne-aryl phosphodiesterase-4 inhibitors
03/06/2003WO2003018576A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity
03/06/2003WO2003018566A1 New piperidinyl derivates as modulators of chemokine receptor activity
03/06/2003WO2003018556A1 Piperidine derivatives useful as modulators of chemokine receptor activity
03/06/2003WO2003018545A1 24-sulfur-substituted analogs of 1α,25-dihydroxy vitamin d¿3?
03/06/2003WO2003018535A2 Novel aminobenzoephenones
03/06/2003WO2003018134A2 Bioadhesive compositions and methods for enhanced mucosal drug absorption
03/06/2003WO2003018077A1 Method of bone regeneration
03/06/2003WO2003018044A1 New drug
03/06/2003WO2003018033A1 Use of fucans in the treatment of adhesions, arthritis and psoriasis
03/06/2003WO2003018020A1 Jnk inhibitors
03/06/2003WO2003017963A1 Oral composition comprising an alkylhydroxybenzoate
03/06/2003WO2003017962A1 Oral composition comprising an alkylhydroxybenzoate
03/06/2003WO2003017940A2 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption
03/06/2003WO2003017939A2 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
03/06/2003WO2003017935A2 Human antibodies specific for interleukin 15 (il-15)
03/06/2003WO2003017919A2 Composition comprising wenguanguo extracts, methods for preparing same and uses therof
03/06/2003WO2003000190A3 Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints
03/06/2003WO2002102381A9 Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage
03/06/2003WO2002096367A3 Targeted multivalent macromolecules
03/06/2003WO2002086069A3 Secreted proteins
03/06/2003WO2002085945A3 Vhh single heavy chain antibody and a method for its preparation in a mammal
03/06/2003WO2002074243A9 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
03/06/2003WO2002066516A3 Antibodies that bind both bcma and taci
03/06/2003WO2002058681A8 Use of rhein for preparing a medicine for treating a high level of il-1
03/06/2003WO2002055507A8 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors
03/06/2003WO2002034726A9 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
03/06/2003WO2002030982A3 Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of use
03/06/2003WO2002028481A3 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
03/06/2003WO2002006478A8 Extracellular matrix protein
03/06/2003WO2001092304A3 Transporters and ion channels
03/06/2003WO2001077146A3 Compounds and methods for modulating endothelial cell adhesion
03/06/2003US20030045728 Indol-3-yl derivatives
03/06/2003US20030045726 Novel immunotherapeutic agents
03/06/2003US20030045583 Novel succinate salt of O-desmethyl-venlafaxine
03/06/2003US20030045574 Such as alpha-phenyl-N-(7-tert-butoxycarbonylamino-3,5-dimethyladamantane)nitrone for treatment of neurological/ inflammatory diorders, and aging, which result from the overproduction of nitric oxide
03/06/2003US20030045565 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
03/06/2003US20030045557 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
03/06/2003US20030045556 Aryl-N-cyanoguanidines and methods related thereto
03/06/2003US20030045552 Isoindole-imide compounds, compositions, and uses thereof
03/06/2003US20030045521 Sulfohydroxamic acids and sulfohydroxamates and their use as MEK inhibitors
03/06/2003US20030045516 Chemokine receptor antagonists and methods of use therefor
03/06/2003US20030045505 Oligosaccharide having at least a D-galactose unit bound by an alpha (1-6) bond with a sucrose unit; second component is a molecule positively charged at physiological pH and that promotes pinocytosis or membrane penetration
03/06/2003US20030045490 Therapeutic antisense phosphodiesterase inhibitors
03/06/2003US20030045474 Pharmaceutical compositions
03/06/2003US20030045460 Orally administered peptides to ameliorate atherosclerosis
03/06/2003US20030045456 Complex comprising OCIF and polysaccharide
03/06/2003US20030044975 Cytokine-binding domain for use in the treatment of asthma and thrombocytopenia
03/06/2003US20030044888 Polypeptide for use in the treatment of addison's disease
03/06/2003US20030042870 Intelligent serial battery charger and charging block
03/06/2003CA2458565A1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain
03/06/2003CA2458443A1 Bioadhesive compositions and methods for enhanced mucosal drug absorption
03/06/2003CA2458131A1 Jnk activation inhibitor
03/06/2003CA2457885A1 Antimicrobial and anti-inflammatory peptides
03/06/2003CA2457879A1 Modulators of bone homeostasis identified in a high-throughput screen
03/06/2003CA2457846A1 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids
03/06/2003CA2451740A1 Composition comprising wenguanguo extracts, methods for preparing same and uses thereof
03/05/2003WO2002020566A2 NOVEL MMP-2 DERIVATIVES FOR USE AS INHIBITORS OF INTEGRIN αVβ¿3?
03/05/2003EP1288299A2 TRNA synthetase
03/05/2003EP1288228A1 BMP-2-derived peptides having osteogenetic activity and osteogenetic accelerator containing the same
03/05/2003EP1288216A1 Tricyclic quinazolinediones
03/05/2003EP1288206A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
03/05/2003EP1288205A1 Novel phenylalanine derivatives
03/05/2003EP1287825A1 Blends comprising a substituted fatty acid or a derivative thereof
03/05/2003EP1287140A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof
03/05/2003EP1287137A2 REGULATION OF HUMAN $g(a)1A?ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
03/05/2003EP1287130A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
03/05/2003EP1287019A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
03/05/2003EP1287017A1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
03/05/2003EP1287015A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
03/05/2003EP1286995A1 2,7-naphthyridine derivatives
03/05/2003EP1286989A2 Prodrug of an ice inhibitor
03/05/2003EP1286986A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
03/05/2003EP1286972A1 Pyrimidine compounds
03/05/2003EP1286966A1 4-aminopiperidine derivatives and their use as medicine
03/05/2003EP1286962A1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds
03/05/2003EP1286693A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
03/05/2003EP1286691A2 Methods for treatment of diseases associated with inflammation under non-ischemic conditions
03/05/2003EP1286690A2 Use of alpha-msh and epo for preventing or treating ischemic conditions
03/05/2003EP1286677A1 Purified material having size and growth inhibitory effects on cells and tissues
03/05/2003EP1286673A2 Ligands of integrin receptors
03/05/2003EP1286667A2 Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases
1 ... 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 ... 820